What is the recommended ceftriaxone dosage for treating typhoid fever in adults and children?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Ceftriaxone for Typhoid Fever

For quinolone-resistant typhoid fever, use ceftriaxone 2-4 grams daily in adults (or 75 mg/kg/day in children, max 4 grams) for 7-14 days, administered intravenously or intramuscularly. This recommendation is based on WHO guidelines and FDA labeling, with azithromycin as the preferred first-line agent for quinolone-resistant strains 1.

Treatment Algorithm Based on Resistance Patterns

First-Line Therapy Selection

  • Fully susceptible S. typhi: Fluoroquinolones (ciprofloxacin, ofloxacin) 1
  • Quinolone-resistant strains: Azithromycin (first choice) or ceftriaxone (second choice) 1
  • Multidrug-resistant (MDR) strains: Fluoroquinolone or cefixime 1

When to Use Ceftriaxone

Ceftriaxone is specifically indicated when:

  • Fluoroquinolones fail clinically despite in vitro susceptibility 2
  • Documented quinolone resistance exists 1
  • Patient cannot tolerate azithromycin
  • Extensively drug-resistant (XDR) strains are suspected

Dosing Recommendations

Adults

  • Standard dose: 1-2 grams once daily IV/IM 3
  • Severe infections: Up to 4 grams daily (maximum dose) 3
  • Duration: 7-14 days, with most evidence supporting 10-14 days 4, 5, 6

Pediatric Patients

  • Standard dose: 50-75 mg/kg/day once daily or divided twice daily 3
  • Maximum: 2 grams/day for most infections; 4 grams/day for severe infections 3
  • Duration: 7-14 days 4, 5

Neonates (≤28 days)

  • Dose: 50-75 mg/kg/day 3
  • Administration: IV infusion over 60 minutes (not 30 minutes) to reduce bilirubin encephalopathy risk 3
  • Critical contraindication: Do NOT use in hyperbilirubinemic or premature neonates, or those requiring calcium-containing IV solutions 3

Duration of Therapy: Key Evidence

The optimal duration remains debated, but 7-day courses show higher relapse rates:

  • 7 days vs 14 days: A randomized trial demonstrated 14% relapse rate with 7-day ceftriaxone (65 mg/kg/day) versus 0% with 14-day treatment in MDR typhoid 5
  • Flexible duration approach: Treatment until defervescence plus 5 additional days showed no relapses and was comparable to 14-day chloramphenicol 4
  • 3-day ultra-short course: While one trial showed 95% cure with 3 grams daily for 3 days in adults, this is not recommended given limited evidence 7

Recommendation: Use 10-14 days of therapy to minimize relapse risk, particularly in children and MDR cases 5, 8.

Comparative Effectiveness

Ceftriaxone vs Azithromycin

Evidence suggests azithromycin may be superior:

  • Lower clinical failure rate (OR 0.48) and shorter hospital stay (-1.04 days) compared to fluoroquinolones 1
  • Significantly lower relapse rate with azithromycin vs ceftriaxone (OR 0.09,95% CI 0.01-0.70) 1
  • Ceftriaxone may have shorter time to defervescence (-0.52 days) 8

Ceftriaxone vs Fluoroquinolones

  • In culture-confirmed cases, ceftriaxone showed lower failure risk (HR 0.24) compared to gatifloxacin 1
  • However, this trial was stopped early due to emerging high-level fluoroquinolone resistance 1
  • Clinical failure with cefixime (oral cephalosporin) was significantly higher than fluoroquinolones (RR 13.39) 8

Critical Administration Warnings

Calcium Interactions

Never mix ceftriaxone with calcium-containing solutions 3:

  • Do not use Ringer's solution or Hartmann's solution for reconstitution
  • Do not administer simultaneously via Y-site with calcium-containing IV solutions
  • In patients >28 days old, may give sequentially if lines thoroughly flushed between infusions
  • Absolute contraindication in neonates receiving calcium-containing solutions

Route of Administration

  • IV preferred for severe cases: Infuse over 30 minutes in adults/children, 60 minutes in neonates 3
  • IM acceptable: Can be used for outpatient treatment or when IV access difficult 3

Common Pitfalls to Avoid

  1. Inadequate duration: Do not stop at 7 days—this increases relapse risk to 14% 5
  2. Relying on Widal test: Blood culture is essential; Widal is nonspecific and unreliable 9
  3. Assuming ciprofloxacin works: Even with in vitro susceptibility, clinical failure occurs frequently; nalidixic acid resistance predicts ciprofloxacin failure requiring 10x higher doses 9, 2
  4. Using cefixime as equivalent: Oral cefixime has significantly higher failure rates than IV ceftriaxone 8
  5. Ignoring local resistance patterns: Resistance varies dramatically by region and changes over time 8

Clinical Response Monitoring

  • Expected defervescence: 4-8 days after starting therapy 4, 6, 7
  • If fever persists >7 days: Consider treatment failure, complications (perforation, abscess), or resistant organism
  • Continue therapy: At least 2 days after fever resolution, typically completing 10-14 day course 3

Special Populations

  • No dose adjustment needed for renal or hepatic impairment up to 2 grams/day 3
  • Elderly patients: Use standard adult dosing if no severe renal/hepatic impairment 3
  • Pregnancy: Use only if clearly needed; crosses placenta but no evidence of teratogenicity 3
  • Nursing mothers: Excreted in low concentrations in breast milk; use with caution 3

References

8
Research

Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.

The Cochrane database of systematic reviews, 2022

9
Research

Typhoid Fever.

Mymensingh medical journal : MMJ, 2008

Related Questions

What is the recommended duration of ceftriaxone therapy for treating typhoid fever?
For typhoid fever, what is the recommended ceftriaxone dose and duration, and when can I step down to oral cefixine (cefexime) instead of completing a full 7‑day IV course?
What are the recommended ceftriaxone and azithromycin dosing regimens for adults and children with complicated typhoid fever?
Can cefixime tablets be administered to a pregnant woman in the third trimester for treatment of typhoid fever?
What are the best intravenous (IV) antibiotics for an intubated patient with typhoid?
In a declining patient with hypotension (blood pressure 99/70 mmHg) who is not taking oral intake, at what rate should an intravenous normal saline (0.9% sodium chloride) infusion be started?
What is the appropriate management of drug‑induced elevation of alkaline phosphatase?
What is the Child‑Pugh score for a patient with bilirubin 2.75 mg/dL, INR 1.9, and ALT 80 U/L?
What oral iron formulation provides the best tolerability for a child younger than 12 years?
Based on bilirubin 2.75 mg/dL, INR 1.9, albumin 2.8 g/dL, no encephalopathy, and no ascites, what is the Child‑Pugh score and class?
How can I treat a child who cannot tolerate ferrous sulfate?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.